在结直肠癌中,PCYT2通过提高YAP1酸化来抑制表皮-介质细胞转换
Lian Zhou1, Su Zhang1, Lingli Wang1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, and Frontiers Science Center for Disease-related Molecular Network, and.
甲胺基基基转移酶2 (PCYT2) 通过促进YAP1降解来抑制结直肠癌转移. 在转移性CRC中PCYT2的下调强调其作为潜在治疗点的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 代谢重编程和Hippo路径失调在瘤转移中至关重要.
- 由其脱化驱动的YAP1核转位促进了转移基因的转录.
- 甲胺基酸转移酶2 (PCYT2) 在转移中的作用在很大程度上是未知的.
研究的目的:
- 为了研究PCYT2在结直肠癌 (CRC) 转移中的功能.
- 阐明PCYT2影响转移的分子机制.
主要方法:
- 在转移性CRC组织中分析PCYT2表达.
- 研究PCYT2,PEBP1,PPP2R1A和YAP1.1.之间的相互作用.
- 评估YAP1的酸化,降解和核转移.
- 评估对ZEB1和SNAIL2转录的影响.
主要成果:
- 在转移性CRC中,PCYT2的调控下降,并起到转移抑制作用.
- PCYT2 增强了 PEBP1 与 PPP2R1A 的相互作用,破坏了 PPP2R1A-YAP1 综合体.
- 这导致YAP1的酸化和随后的降解增加,从而减少了核YAP1.
- 减少的核YAP1抑制ZEB1和SNAIL2,抑制转移.
结论:
- 在结直肠癌中,PCYT2 作为瘤转移抑制剂起作用.
- PCYT2通过PEBP1-PPP2R1A-YAP1轴和随后的YAP1降解来调节转移.
- PCYT2代表了抑制CRC转移的潜在治疗标.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Induced Pluripotent Stem Cells
Somatic...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
